1. Challenges and Opportunities in the Management of ANCA-Associated Vasculitis

3. Vasculitis Overview

4. Patient, KB Initial Presentation

5. Work Up

6. Signs of Severe Disease: GPA

7. Induction Regimen Selection

8. Choosing Between CYC and RTX Favors RTX

10. RTX + CYC

11. RTX Dosing

12. CYC Dosing and Safety

13. Plasma Exchange in AAV

14. Plasma Exchange in KB

15. KB Follow-Up 1 Month

16. Monitoring the AAV Patient

17. KB Follow-up, Laboratory Results

18. Treating KB

19. KB Follow-up, 4 Months

20. Further Prednisone Taper

21. Considerations for Adding Another Agent

22. Maintenance Therapies

23. Maintenance Therapies (cont.)

24. KB Follow-up, 9 Months

25. Change KB’s Treatment Regimen?

26. KB Follow-up, 12 Months

27. Treating Relapse Considerations

28. Abbreviations